Evidence map›Paper›PMID 41264039›Full record

ArticleHead and neck pathology2025

YAP1::MAML2-Rearranged Poroid Squamous Cell Carcinoma Arising in a Non-sebaceous Lymphadenoma of the Parotid Gland.

Kevin E Mijares, Abigail I Wald, Raja R Seethala

Abstract readCase Reports
In one paragraph

Article in Head and neck pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kevin E MijaresDepartment of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center - Presbyterian University Hospital, A607, UPMC Presbyterian, 200 Lothrop St, Pittsburgh, PA, 15213, USA. kevin_mijares@yahoo.com.
Abigail I WaldDepartment of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center - Presbyterian University Hospital, A607, UPMC Presbyterian, 200 Lothrop St, Pittsburgh, PA, 15213, USA.
Raja R SeethalaDepartment of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center - Presbyterian University Hospital, A607, UPMC Presbyterian, 200 Lothrop St, Pittsburgh, PA, 15213, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salivary gland lymphadenoma is an uncommon neoplasm and malignant transformation is even rarer. Reported tumor types include basal cell adenocarcinoma, sebaceous carcinoma, EBV-associated lymphoepithelial carcinoma, and undifferentiated carcinoma; a squamous phenotype has not been reported. Here we describe the case of a 62-year-old female who underwent total parotidectomy for a painful parotid gland mass of uncertain duration. On microscopic examination, a high grade lymphoepithelial carcinoma with squamous and poroid features arising in a non-sebaceous lymphadenoma was recognized. Both benign and malignant components expressed CK5/6 and ΔNp63 (p40), however SOX2 was overexpressed in the malignant component. S100, SOX10, CD117, PLAG1 and HMGA2 immunostains were negative. In-situ hybridization for high-risk HPV RNA and EBER were also negative. Fluorescence in situ hybridization revealed MAML2 rearrangement with RNASeq confirming a YAP1::MAML2 fusion product. This case highlights a novel salivary gland malignancy type arising from lymphadenoma, for which molecular testing was critical in establishing primary origin, and thus excluding the more common metastatic squamous cell carcinoma.

Indexed as

Adaptor Proteins, Signal TransducingCarcinoma, Squamous CellDNA-Binding ProteinsParotid NeoplasmsTrans-ActivatorsTranscription FactorsFemaleGene RearrangementHumansMiddle AgedYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingDNA-Binding ProteinsMAML2 protein, humanTrans-ActivatorsTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsLymphadenomaPorocarcinomaSalivary glandSquamous cell carcinomaYAP1::MAML2

Identifiers

PMID41264039
PMCPMC12634969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.